- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 16/18 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans
Patent holdings for IPC class C07K 16/18
Total number of patents in this class: 11052
10-year publication summary
806
|
951
|
946
|
1016
|
963
|
1025
|
922
|
898
|
738
|
226
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Immatics Biotechnologies GmbH | 1144 |
236 |
Genentech, Inc. | 3742 |
173 |
Alexion Pharmaceuticals, Inc. | 606 |
169 |
The Regents of the University of California | 18943 |
133 |
Ablynx N.V. | 377 |
129 |
Regeneron Pharmaceuticals, Inc. | 3650 |
114 |
Amgen Inc. | 3779 |
112 |
Prothena Biosciences Limited | 184 |
105 |
Chugai Seiyaku Kabushiki Kaisha | 1259 |
104 |
F. Hoffmann-La Roche AG | 7958 |
96 |
Eli Lilly and Company | 3645 |
91 |
AC Immune S.A. | 234 |
85 |
Hoffmann-La Roche Inc. | 3060 |
73 |
H. Lundbeck A/S | 1252 |
73 |
Novartis AG | 11238 |
72 |
The Trustees of the University of Pennsylvania | 4122 |
72 |
Sanofi | 3836 |
67 |
Bristol-myers Squibb Company | 5080 |
60 |
Philogen S.p.A. | 120 |
59 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
54 |
Other owners | 8975 |